ExoStemTech
PrivateLast Round
Strategic
Dec 1, 2021
Est. Valuation
$71.4M
Total Funding Raised
$12.03M
Company Overview
ExoStemTech operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Strategic round in December 2021.
ExoStemTech is a biotechnology company that develops exosome-based therapeutic systems for tissue repair and regeneration, focusing on conditions such as osteoarthritis, liver fibrosis, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExoStemTech Comparables
Compare ExoStemTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BREXOGEN Inc. | 89% | |
| ILIAS Biologics Inc. | 87% | |
| EVerZom | 81% |
For institutional investors. Book with your work email.
ExoStemTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 1, 2021 | ||||
| Series B | Oct 26, 2021 |
For institutional investors. Book with your work email.
ExoStemTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series B, Series A |
| Hana Securities | Series B |
| We Ventures | Series B |
| IMM Investment | Series B, Series A |
| Laguna Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2021
Daewoong Pharmaceutical participated in the round.
- Oct 26, 2021
$8.4M round led by DSC Investment.
For institutional investors. Book with your work email.
ExoStemTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExoStemTech's valuation, stock price, and market status.
Is ExoStemTech a public or private company?
ExoStemTech is a private company.
What is the current stock price of ExoStemTech?
ExoStemTech is a private company, so its shares have no public market price. Caplight tracks ExoStemTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExoStemTech worth (valuation)?
ExoStemTech's valuation is estimated at $71.4M based on funding round data.
Can I buy ExoStemTech stock?
ExoStemTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExoStemTech's last funding round?
ExoStemTech's most recent funding round was Strategic on December 1, 2021.
Who are the main investors in ExoStemTech?
Key investors in ExoStemTech include DSC Investment, Hana Securities, We Ventures, IMM Investment, Laguna Investment.
Will ExoStemTech IPO soon?
No public IPO plans have been announced for ExoStemTech.
How can I track ExoStemTech secondary market activity?
Caplight tracks bids, offers, and trades in ExoStemTech's shares on secondary markets.